results of phase ii study of bomedemstat in myelofibrosis
Published 2 years ago • 241 plays • Length 5:40Download video MP4
Download video MP3
Similar videos
-
7:42
phase ii trial of bomedemstat for advanced myelofibrosis
-
2:36
phase ii study of pre-, during-, and post-transplant ruxolitinib for patients with myelofibrosis
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
7:10
bomedemstat in jak inhibitor-resistant myelofibrosis
-
2:41
bomedemstat combined with ruxolitinib for the treatment of mf: early results of a phase ii trial
-
2:15:59
revision sessin 1 - final exam
-
4:17
treatment sequencing and ongoing clinical trials in anemic myelofibrosis
-
24:30
practical applications for quality improvement in myelofibrosis management: a video brief on less...
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:25
the current approach to managing patients with prefibrotic pmf
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:49
results from manifest phase ii study of pelabresib for anemia associated with myelofibrosis
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
1:17
phase ii study of tosedostat in mds
-
1:49
phase ii trial-in-progress of itacitinib in patients with myelofibrosis
-
1:53
parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib
-
3:43
updated results from manifest arm 2: pelabresib as add-on to ruxolitinib in myelofibrosis
-
1:30
optimal approach to first-line therapy in myelofibrosis